BeOne Medicines
ONC
#647
Rank
$36.12 B
Marketcap
$326.49
Share price
1.11%
Change (1 day)
57.25%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

BeOne Medicines (ONC) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : $3.50 Billion USD

According to BeOne Medicines's latest financial reports the company's total liabilities are $3.50 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BeOne Medicines - Total liabilities on balance sheet (from 2014 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31$2.58 B14.14%
2023-12-31$2.26 B13.63%
2022-12-31$1.99 B-16.94%
2021-12-31$2.40 B38.78%
2020-12-31$1.73 B173.14%
2019-12-31$0.63 B27.8%
2018-12-31$0.49 B36.93%
2017-12-31$0.36 B584.7%
2016-12-31$52.9 M24.65%
2015-12-31$42.44 M52.39%
2014-12-31$27.85 M-44.87%
2013-12-31$50.52 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Onconova Therapeutics
ONTX
$12.15 M-99.65%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
$0.69 B-80.30%๐Ÿ‡บ๐Ÿ‡ธ USA